As the U.S. Food and Drug Administration (FDA) seeks to modernise its regulatory processes,...
Balancing Enforcement and Innovation: CTP’s Post-RIF Strategy in Focus
As the U.S. Food and Drug Administration’s Center for Tobacco Products (CTP) adjusts to a new era of leadership and reduced staffing, a clearer regulatory direction is beginning to emerge. Following months of internal restructuring and uncertainty,...
All articles
Since January 2025, the regulatory landscape for tobacco and nicotine products in the United States...
Broughton has been engaged in collaborative discussions with the European Directorate for the...
When developing a nicotine product, the choice between freebase nicotine and nicotine salts plays a...
Chromatography is a cornerstone of analytical testing for nicotine products. It allows us to...
In the evolving world of cannabis science, terpenes are stepping out of the background. These...
Our Chief Commercial Officer, Andy Mooney, recently attended the Global Forum on Nicotine (GFN)...
Why MMAD Testing Matters in Inhalation Product Development
Bringing a medical device to market isn’t just about innovation—it’s about precision, compliance,...
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
